According to a comprehensive review published in JAMA in 2026, true resistant hypertension significantly increases the risk of stroke, myocardial infarction, heart failure, kidney failure, and cardiovascular mortality.

What Is Resistant Hypertension?

Resistant hypertension is defined as persistently elevated blood pressure despite treatment with at least three antihypertensive medications from different classes at the maximum tolerated doses. These typically include:

An angiotensin-converting enzyme inhibitor (ACE inhibitor) or angiotensin receptor blocker (ARB)
A calcium channel blocker
A diuretic
Before establishing the diagnosis, clinicians must exclude causes of “pseudo-resistance,” such as white-coat hypertension (elevated blood pressure only in clinical settings), poor medication adherence, or secondary causes of hypertension.

Who Is at Higher Risk?

Studies indicate that true resistant hypertension affects approximately 10.3% of treated hypertensive patients and rises to as high as 22.9% among individuals with chronic kidney disease.

High-risk groups include:

Patients with chronic kidney disease
Individuals with diabetes mellitus
Overweight or obese individuals
Patients with established cardiovascular disease
Older adults
Men
Individuals with obstructive sleep apnea
People who consume alcohol regularly

Treatment: More Than Just Medication

Experts emphasize that lifestyle modification is the cornerstone of managing resistant hypertension.

Patients are advised to:

Reduce sodium intake to less than 1,500 mg per day
Limit alcohol consumption
Engage in at least 150 minutes of physical activity per week
Maintain a healthy body weight
Follow the DASH (Dietary Approaches to Stop Hypertension) diet, rich in vegetables, fruits, and whole grains
Regarding pharmacological therapy, the preferred regimen consists of a combination of three drug classes: an ACE inhibitor/ARB, a calcium channel blocker, and a thiazide-type diuretic.

For patients with confirmed resistant hypertension, spironolactone is considered one of the most effective add-on therapies when not contraindicated.

In cases where optimal medical treatment fails to achieve adequate blood pressure control, renal sympathetic denervation may be considered. Although this minimally invasive procedure has shown sustained blood pressure reduction, it remains costly and is effective in approximately two-thirds of patients.

Significantly Higher Risk of Complications

Research consistently demonstrates that patients with resistant hypertension are at substantially greater risk of damage to the heart, brain, kidneys, and blood vessels compared with those whose blood pressure is well controlled.

The risks of stroke, heart failure, and cardiovascular death are also markedly increased.

Experts recommend that patients with hypertension attend regular follow-up visits, adhere strictly to prescribed treatment, and avoid discontinuing medications without medical advice. Early recognition of resistant hypertension and timely optimization of therapy can significantly reduce the risk of severe complications and help protect long-term cardiovascular health.

Source: JAMA, 2026